Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Asset disposition
Quarterly results
CC transcript
|
|
CHINA MEDICINE CORP (CHME)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2010 |
8-K
| Asset disposition|
Docs:
|
"Certificate of Designation, Rights and Preferences, Redeemable Convertible Preferred Stock",
"China Medicine Corporation Announces Closing of Financing, New Board Member Guangzhou, China, February 2, 2010 -- China Medicine Corporation , primarily a developer, manufacturer and leading distributor in China of Western pharmaceuticals, traditional Chinese medicines , and other nutriceuticals, today announced that it has closed the equity private placement contemplated in its Stock Subscription Agreement dated December 31, 2009 with One Equity Partners , the global private equity investment arm of JPMorgan Chase & Co. At closing, China Medicine sold 4,000,000 of the Company’s common shares at $3.00 per share for $12 million in gross proceeds and 1,920,000 of its redeemable convertible preferred shares at $30 per share for $57.6 million in gross proceeds resulting in aggregate net procee..." |
|
|
|